Servier Austria

Servier Austria company information, Employees & Contact Information

Explore related pages

Related company profiles:

Servier ist ein internationales und forschendes Pharmaunternehmen. Entsprechend unserem Leitbild stellen wir die Bedürfnisse von Patienten und Innovationen in den Mittelpunkt aller Aktivitäten. Servier investiert über 20% des Umsatzes jährlich in Forschung und Entwicklung – zusätzlich haben wir hohe Investitionen in unser neues Innovations- und Forschungszentrum in Paris-Saclay investiert. Das Unternehmen erstreckt seine internationale Präsenz über 150 Länder und beschäftigt etwa 21.800 Mitarbeiter, davon rund 50 Mitarbeiter in Österreich. Die wichtigsten Indikationsgebiete sind: Onkologie, Neurologie, immunentzündliche Erkrankungen sowie Herz-Kreislauf und Diabetes. Servier Austria ist ein familienfreundlicher Arbeitgeber! Um eine Nebenwirkung zu unseren Produkten zu melden, kontaktieren Sie uns bitte über unser Kontaktformular auf unserer Homepage unter: https://servier.at/kontaktieren-sie-uns/

Company Details

Employees
29
Industry
Wholesale
NAICS
Wholesale Trade
Merchant Wholesalers, Durable Goods
Merchant Wholesalers, Nondurable Goods
Office Equipment Merchant Wholesalers
Other Commercial Equipment Merchant Wholesalers
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Ophthalmic Goods Merchant Wholesalers
Other Professional Equipment and Supplies Merchant Wholesalers
Sporting and Recreational Goods and Supplies Merchant Wholesalers
Toy and Hobby Goods and Supplies Merchant Wholesalers
Other Miscellaneous Durable Goods Merchant Wholesalers
Farm Supplies Merchant Wholesalers
Book, Periodical, and Newspaper Merchant Wholesalers
Flower, Nursery Stock, and Florists' Supplies Merchant Wholesalers
Tobacco and Tobacco Product Merchant Wholesalers
Paint, Varnish, and Supplies Merchant Wholesalers
Other Miscellaneous Nondurable Goods Merchant Wholesalers
Professional and Commercial Equipment and Supplies Merchant Wholesalers
Keywords
Servier China.
Looking for a particular Servier Austria employee's phone or email?

Servier Austria Questions

News

Collaborating for Success: A Q&A with Servier on External Innovation - Massachusetts Biotechnology Council

Collaborating for Success: A Q&A with Servier on External Innovation Massachusetts Biotechnology Council

Baker McKenzie advises Servier on the acquisition of a potential treatment for Fragile X syndrome - Baker McKenzie

Baker McKenzie advises Servier on the acquisition of a potential treatment for Fragile X syndrome Baker McKenzie

Dentons advises Servier on the sale of Biogaran - Dentons

Dentons advises Servier on the sale of Biogaran Dentons

Jeff Knipstein: What’s next for Servier in IDH-mutant glioma - Oncodaily

Jeff Knipstein: What’s next for Servier in IDH-mutant glioma Oncodaily

Baker McKenzie Steers Servier On $450M Autism Drug Buy - Law360

Baker McKenzie Steers Servier On $450M Autism Drug Buy Law360

Black Diamond Therapeutics Partners with Servier for BDTX-4933 - TipRanks

Black Diamond Therapeutics Partners with Servier for BDTX-4933 TipRanks

Servier at ASH meeting to present new data in hematology research - Servier

Servier at ASH meeting to present new data in hematology research Servier

French Pharma Giant Launches Research Institute - Site Selection Magazine

French Pharma Giant Launches Research Institute Site Selection Magazine

Servier on the hook for €471 million over Mediator diet pill scandal - FirstWord Pharma

Servier on the hook for €471 million over Mediator diet pill scandal FirstWord Pharma

PRISM BioLab, a new partner for Servier in immuno-oncology - Servier

PRISM BioLab, a new partner for Servier in immuno-oncology Servier

The Group in figures - Servier

The Group in figures Servier

Committed to and with patients - Servier

Committed to and with patients Servier

Servier on the front line of cardiovascular disease prevention and therapeutic adherence - Servier

Servier on the front line of cardiovascular disease prevention and therapeutic adherence Servier

Servier, buoyed by high-performance R&D, confirms its 2025 trajectory to achieve its 2030 ambition - Servier

Servier, buoyed by high-performance R&D, confirms its 2025 trajectory to achieve its 2030 ambition Servier

See our bases throughout the world - Servier

See our bases throughout the world Servier

Discover in video the commitment of Servier in oncology - Servier

Discover in video the commitment of Servier in oncology Servier

Pancreatic Cancer: Aitia and Servier will collaborate - Servier

Pancreatic Cancer: Aitia and Servier will collaborate Servier

Integrated annual report 2023/2024 - Servier

Integrated annual report 2023/2024 Servier

Servier Executive Committee appointments - Servier

Servier Executive Committee appointments Servier

Appointment of Walid S. Kamoun, PhD. MSc., Global Head of Servier R&D Oncology - Servier

Appointment of Walid S. Kamoun, PhD. MSc., Global Head of Servier R&D Oncology Servier

EU Court of Justice Takes a Firm Stance Against Patent Settlement Agreements - Skadden, Arps, Slate, Meagher & Flom LLP

EU Court of Justice Takes a Firm Stance Against Patent Settlement Agreements Skadden, Arps, Slate, Meagher & Flom LLP

Therapeutic adherence: a new campaign to build awareness - Servier

Therapeutic adherence: a new campaign to build awareness Servier

Agios offloads oncology unit to Servier in $1.8B deal, zeroes in on genetically defined diseases - Fierce Biotech

Agios offloads oncology unit to Servier in $1.8B deal, zeroes in on genetically defined diseases Fierce Biotech

The Servier Case: The Game isn’t Over Yet - Dechert

The Servier Case: The Game isn’t Over Yet Dechert

Drugmaker Servier loses EU court fight over pay-for-delay deals - Reuters

Drugmaker Servier loses EU court fight over pay-for-delay deals Reuters

The truth about hypertension - Daily Tribune

The truth about hypertension Daily Tribune

Aitia Expand Collaboration with Servier to Discover and Develop New Drugs for Brain Cancer Using AI-Driven Digital Twins - PR Newswire

Aitia Expand Collaboration with Servier to Discover and Develop New Drugs for Brain Cancer Using AI-Driven Digital Twins PR Newswire

Shire to sell oncology unit to Servier for $2.4 billion - FirstWord Pharma

Shire to sell oncology unit to Servier for $2.4 billion FirstWord Pharma

Servier signs first neurology-focused deal, gaining Kaerus' Fragile X hopeful - FirstWord Pharma

Servier signs first neurology-focused deal, gaining Kaerus' Fragile X hopeful FirstWord Pharma

The Research and Development Institute in Paris-Saclay - Servier

The Research and Development Institute in Paris-Saclay Servier

World Anti-Counterfeiting Day: on the front line for patient safety - Servier

World Anti-Counterfeiting Day: on the front line for patient safety Servier

Servier pays $70M to polish Black Diamond's deprioritized solid tumor prospect - Fierce Biotech

Servier pays $70M to polish Black Diamond's deprioritized solid tumor prospect Fierce Biotech

Pancreatic cancer: a new treatment available for Argentine patients - Servier

Pancreatic cancer: a new treatment available for Argentine patients Servier

Rigel scores green light in AML just 4 months after buying asset from Forma - Fierce Pharma

Rigel scores green light in AML just 4 months after buying asset from Forma Fierce Pharma

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles - Reuters

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles Reuters

IQVIA teams up with French pharma Servier to 'reinvent clinical development' - Fierce Biotech

IQVIA teams up with French pharma Servier to 'reinvent clinical development' Fierce Biotech

French Pharma Firm Ordered to Pay Millions Over Deadly Diabetes Drug - VOA - Voice of America English News

French Pharma Firm Ordered to Pay Millions Over Deadly Diabetes Drug VOA - Voice of America English News

Shire Sells Cancer Drugs to Servier for $2.4 Billion As Takeda Circles - businessinsider.com

Shire Sells Cancer Drugs to Servier for $2.4 Billion As Takeda Circles businessinsider.com

Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors - Business Wire

Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors Business Wire

French Court Fines Servier for Damages Caused by Weight-Loss Drug Mediator - BioSpace

French Court Fines Servier for Damages Caused by Weight-Loss Drug Mediator BioSpace

Shire sells cancer-treatment business to France’s Servier in $2.4bn deal - theneweconomy.com

Shire sells cancer-treatment business to France’s Servier in $2.4bn deal theneweconomy.com

Jacques Servier, 92, Dies; Accused of Hiding the Risks of Drugs (Published 2014) - The New York Times

Jacques Servier, 92, Dies; Accused of Hiding the Risks of Drugs (Published 2014) The New York Times

Servier opens Kendall Square site, plans Chinese office to access external innovation - Fierce Biotech

Servier opens Kendall Square site, plans Chinese office to access external innovation Fierce Biotech

UK Supreme Court rules in favour of Servier in NHS patent lawsuit - PMLiVE

UK Supreme Court rules in favour of Servier in NHS patent lawsuit PMLiVE

Servier v. Commission (Case T 691/14): 5 crucial points of the second “pay-for-delay” decision of the EU General Court - Wolters Kluwer

Servier v. Commission (Case T 691/14): 5 crucial points of the second “pay-for-delay” decision of the EU General Court Wolters Kluwer

Shire completes sale of oncology franchise to Servier - PharmaTimes

Shire completes sale of oncology franchise to Servier PharmaTimes

Black Diamond Therapeutics, Inc. SEC 10-Q Report - TradingView

Black Diamond Therapeutics, Inc. SEC 10-Q Report TradingView

Seven Monckton barristers act for NHS claimants in milestone judgment against pharma company Servier in its attempt to limit damages in “pay for delay” perindopril case - Monckton Chambers

Seven Monckton barristers act for NHS claimants in milestone judgment against pharma company Servier in its attempt to limit damages in “pay for delay” perindopril case Monckton Chambers

Servier in new collaboration with Melbourne's BioCurate - BiotechDispatch

Servier in new collaboration with Melbourne's BioCurate BiotechDispatch

Egis distances itself from parent’s scandal - BBJ - Budapest Business Journal

Egis distances itself from parent’s scandal BBJ - Budapest Business Journal

Repositioning Nigeria’s pharmaceutical industry for competitiveness - Businessday NG

Repositioning Nigeria’s pharmaceutical industry for competitiveness Businessday NG

Gorey Tidy Towns receive €500 from Wicklow company - The Irish Independent

Gorey Tidy Towns receive €500 from Wicklow company The Irish Independent

'Campaign' targets depression guru Ian Hickie - The Australian

'Campaign' targets depression guru Ian Hickie The Australian

Cybersecur­ity awareness campaign to be launched soon - PressReader

Cybersecur­ity awareness campaign to be launched soon PressReader

Top Servier Austria Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant